Rabbit Monoclonal SPIKE antibody. Carrier free. Suitable for Neut and reacts with MERS-CoV samples.
pH: 7 - 7.4
Constituents: 100% PBS
Neut | |
---|---|
MERS-CoV | Tested |
Species | Dilution info | Notes |
---|---|---|
Species MERS-CoV | Dilution info - | Notes - |
Rabbit Monoclonal SPIKE antibody. Carrier free. Suitable for Neut and reacts with MERS-CoV samples.
pH: 7 - 7.4
Constituents: 100% PBS
The MERS Spike glycoprotein also known as MERS-S is an important structural component of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). It is a transmembrane protein with an approximate mass of 180 kDa. Spike glycoprotein is expressed on the virion surface and facilitates the virus attachment and entry into host cells by interacting with host cell receptors. This interaction is mechanistic where the protein undergoes a conformational change to mediate membrane fusion leading to viral entry.
The MERS Spike glycoprotein plays an active role in the infection process of the host. It forms a complex known as a trimer which is essential for the virus’s ability to infect host cells. This protein complex is important for recognizing and binding to the host receptor dipeptidyl peptidase 4 (DPP4) initiating the process of viral entry into host cells. Because of its pivotal function the MERS Spike glycoprotein is a primary target for developing neutralizing antibodies and vaccines.
The entry of MERS-CoV into host cells involves the modulation of endocytic pathways and membrane fusion pathways. The glycoprotein’s interaction with DPP4 activates a cascade of cellular signaling events that facilitate viral endocytosis. Other proteins involved in this pathway include cathepsins which are proteases that assist in activating the spike protein for membrane fusion. These interactions illustrate the spike protein's critical positioning in cellular invasion pathways.
MERS Spike glycoprotein is directly associated with the pathogenesis of Middle East Respiratory Syndrome (MERS) a severe respiratory illness. The protein’s ability to mediate viral entry through DPP4 interaction links it not only to MERS but also to the progression of inflammation in infected tissues. Understanding the spike glycoprotein's function is important for developing therapeutic strategies to treat or prevent MERS-associated disease.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
ab281953 inhibits the infection of Caco-2 cells induced by MERS-CoV pseudovirus with ED50 = 2.5 - 11.0 ng/ml.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com